Your browser doesn't support javascript.
loading
COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021.
van Ewijk, Catharina E; Kooijman, Marjolein N; Fanoy, Ewout; Raven, Stijn Fh; Middeldorp, Marit; Shah, Anita; de Gier, Brechje; de Melker, Hester E; Hahné, Susan Jm; Knol, Mirjam J.
Affiliation
  • van Ewijk CE; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Kooijman MN; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
  • Fanoy E; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
  • Raven SF; Department of Infectious Diseases, Public Health Service Amsterdam-Amstelland, Amsterdam, the Netherlands.
  • Middeldorp M; Department of Infectious Diseases, Public Health Service Utrecht region, Utrecht, The Netherlands.
  • Shah A; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
  • de Gier B; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
  • de Melker HE; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
  • Hahné SJ; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
  • Knol MJ; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
Euro Surveill ; 27(45)2022 11.
Article in En | MEDLINE | ID: mdl-36367011

Full text: 1 Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans / Middle aged Country/Region as subject: Europa Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans / Middle aged Country/Region as subject: Europa Language: En Year: 2022 Type: Article